Europe PCR for Respiratory Infection Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Real-Time PCR (qPCR), Multiplex PCR, Traditional PCR, Digital PCR, Reverse-Transcriptase (RT-PCR), and Others), Product Type (Reagents & Kits, Instruments, and Others), Infection Type (Bacterial Infections, Viral Infections, and Fungal & Other Pathogens); End User (Hospitals, Physician Clinics, Clinical Laboratories, Academic & Research Institutions, Biotech & Pharma Companies, and Others), and Country

Publication Month: Jun 2021 | Report Code: TIPRE00023049 | No. of Pages: 229 | Category: Medical Device | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Europe PCR for respiratory infection diagnostics market is expected to reach US$ 2,432.46 million by 2028 from US$ 1,241.01 million in 2021. The market is estimated to grow at a CAGR of 10.1% from 2021 to 2028.

 

Increasing burden of chronic respiratory diseases (CRDs) and growing developments for PCR testing are expected to propel the growth of the market. However, availability of alternative assays is the major factor hindering the Europe PCR for Respiratory Infection Diagnostics market growth.

 

The demand for PCR testing to diagnose infectious diseases has significantly risen in the past few years. The growing technological advancements have added an extra advantage of point-of-care testing through PCR, which has surged the demand for PCR diagnostics. In addition, the demand is exponentially raised due to the outbreak of COVID-19. Since the pandemic has initiated, reverse transcription-polymerase reaction (RT-PCR) test has been preferably used to diagnose and examine the genetic material of SARS-CoV-2 RNA. The RT-PCR method is widely accepted as the gold standard for the detection of SARS-CoV-2 RNA due to its sensitive testing. Therefore, considering the demand for PCR testing, various market players have introduced PCR products and entered strategic developments in the European market.

 

•     In October 2020, Eurofins launched EmpowerDX SARS CoV 2 RT PCR test that can be used as a home sampling option in Europe. The product was commercialized after receiving Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA). The EmpowerDX SARS CoV 2 RT PCR test is made available in the countries such as Germany and Spain through online distribution channels. The company is looking forward to launching such products in countries such as the UK, France, Belgium, the Netherlands, and Sweden after receiving approval from the regulatory bodies. Also, Eurofins developed a similar version of EmpowerDX SARS CoV 2 RT PCR test through subsidiary Eurofins Viracor in March 2020. The developed COVID-19 PCR test is intended to identify VUI-2020-12/01 strain, which was reported as fast spreading in the UK.

 

•     In October 2020, Synlab, a leading medical diagnostic service provider in Europe, announced the scaling up of testing capacities throughout the entire SYNLAB network. The increase in the capacity is done to effectively meet the increasing demand locally and from other European countries for SARS-CoV-2 testing. Synlab has also agreed with the Ministry of Health, Welfare, and Sport of the Kingdom of the Netherlands to provide enhanced capacities of RT-PCR testing for SARS-CoV-2.

 

•     In December 2020, Bruker Corporation announced its FluoroType SARS-CoV-2/Flu/RSV winter four-plex PCR panel. FluoroType SARS-CoV-2/Flu/RSV winter four-plex PCR panel enables the sensitive and simultaneous detection of the SARS-CoV-2 virus present in both types of influenza A and B viruses and respiratory syncytial virus (RSV). According to the European IVD Directive (98/79/EC), the FluoroType SARS-CoV-2/Flu/RSV panel is CE-IVD labeled. The product is validated for nasopharyngeal swabs, oropharyngeal swabs, and saliva samples. The kit offered by the company includes all reagents to generate 96 PCR result panels in time of two hours after nucleic acid extraction.

 

Europe PCR for Respiratory Infection Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :


 

Europe PCR for Respiratory Infection Diagnostics – Market Segmentation

 

Europe PCR for Respiratory Infection Diagnostics Market – by Type

  • Real-Time PCR (qPCR)
  • Multiplex PCR
  • Traditional PCR
  • Digital PCR
  • Reverse-Transcriptase (RT-PCR)
  • Others

 

Europe PCR for Respiratory Infection Diagnostics Market – by Product Type

  • Reagents and Kits
  • Instruments
  • Others

 

Europe PCR for Respiratory Infection Diagnostics Market – by Infection Type

  • Bacterial Infections
    • Bordetella
    • Streptococcus Pneumoniae
    • Staphylococcus Aureus
    • Haemophilus Influenzae
    • Moraxella Catarrhalis
    • Mycoplasma Pneumoniae
    • Chlamydophila Pneumoniae
    • Legionella
    • Others
  • Viral Infections
    • Rhinoviruses
    • Influenza Virus
    • Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
    • Respiratory Syncytial Virus (RSV)
    • Adenovirus
    • Enterovirus
    • Parainfluenza
    • Human Metapneumovirus (hMPV)
    • Others
  • Fungal and Other Pathogens

 

Europe PCR for Respiratory Infection Diagnostics Market – by End User

  • Hospitals
  • Physician Clinics
  • Clinical Laboratories
  • Academic and Research Institutions
  • Biotech and Pharma Companies
  • Others

 

Company Profiles

  • Abbott
  • F. Hoffmann-LA Roche Ltd.
  • Hologic, Inc.
  • BD
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Qiagen
  • Thermo Fisher Scientific Inc
  • Seegene Inc
  • AusDiagnostics

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Europe PCR for Respiratory Infection Diagnostics Market – By Type

1.3.2        Europe PCR for Respiratory Infection Diagnostics Market – By Product Type

1.3.3        Europe PCR for Respiratory Infection Diagnostics Market – By Infection Type

1.3.4        Europe PCR for Respiratory Infection Diagnostics Market – By End User

1.3.5        Europe PCR for Respiratory Infection Diagnostics Market – By Geography

2.          PCR for Respiratory Infection Diagnostics Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          PCR for Respiratory Infection Diagnostics Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Europe– PEST Analysis

4.3        Expert Opinion

5.          PCR for Respiratory Infection Diagnostics Market – Key Market Dynamics

5.1        Market Drivers

5.1.1        Increasing Burden of Chronic Respiratory Diseases (CRDs)

5.1.2        Growing Developments in PCR Testing

5.2        Market Restraints

5.2.1        Availability of Alternative Assays

5.3        Market Opportunities

5.3.1        Use of PCR Testing for Various Respiratory Infection Diagnostics

5.4        Future Trends

5.4.1        Developments in PCR Technology

5.5        Impact Analysis

6.          PCR for Respiratory Infection Diagnostics Market – Regional Analysis

6.1        Europe PCR for Respiratory Infection Diagnostics Market Revenue Forecast And Analysis

6.2        Market Positioning

7.          PCR for Respiratory Infection Diagnostics Market Analysis – By Type

7.1        Overview

7.2        PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2020 and 2028)

7.3        Real Time PCR

7.3.1        Overview

7.3.2        Real Time PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4        Multiplex PCR

7.4.1        Overview

7.4.2        Multiplex PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5        Traditional PCR

7.5.1        Overview

7.5.2        Traditional PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6        Digital PCR

7.6.1        Overview

7.6.2        Digital PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7        Reverse Transcriptase (RT-PCR)

7.7.1        Overview

7.7.2        Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.8        Others

7.8.1        Overview

7.8.2        Others: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.          PCR for Respiratory Infection Diagnostics Market Analysis – By Product Type

8.1        Overview

8.2        PCR for Respiratory Infection Diagnostics Market Revenue Share, by Product Type (2020 and 2028)

8.3        Reagents and kits

8.3.1        Reagents and kits: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4        Instruments

8.4.1        Overview

8.4.2        Instruments: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5        Others

8.5.1        Overview

8.5.2        Others: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.          PCR for Respiratory Infection Diagnostics Market– By Infection Type

9.1        Overview

9.2        PCR for Respiratory Infection Diagnostics Market Revenue Share, by Infection Type (2020 and 2028)

9.3        Bacterial Infection

9.3.1        Overview

9.3.2        Bacterial Infection: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.3        Bordetella

9.3.3.1          Overview

9.3.3.2          Bordetella: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.4        Streptococcus Pneumoniae

9.3.4.1          Overview

9.3.4.2          Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.5        Staphylococcus Aureus

9.3.5.1          Overview

9.3.5.2          Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.6        Haemophilus Influenzae

9.3.6.1          Overview

9.3.6.2          Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.7        Moraxella Catarrhalis

9.3.7.1          Overview

9.3.7.2          Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.8        Mycoplasma Pneumoniae

9.3.8.1          Overview

9.3.8.2          Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.9        Chlamydophila Pneumoniae

9.3.9.1          Overview

9.3.9.2          Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.10     Legionella

9.3.10.1       Overview

9.3.10.2       Legionella: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.11     Others

9.3.11.1       Overview

9.3.11.2       Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4        Viral Infection

9.4.1        Overview

9.4.2        Viral Infection: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.3        Rhinoviruses

9.4.3.1          Overview

9.4.3.2          Rhinoviruses: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.4        Influenza Virus

9.4.4.1          Overview

9.4.4.2          Influenza Virus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.5        Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus

9.4.5.1          Overview

9.4.5.2          Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.6        Respiratory Syncytial Virus (RSV)

9.4.6.1          Overview

9.4.6.2          Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.7        Adenovirus

9.4.7.1          Overview

9.4.7.2          Adenovirus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.8        Enterovirus

9.4.8.1          Overview

9.4.8.2          Enterovirus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.9        Parainfluenza

9.4.9.1          Overview

9.4.9.2          Parainfluenza: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.10     Human Metapneumovirus (hMPV)

9.4.10.1       Overview

9.4.10.2       Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.11     Others

9.4.11.1       Overview

9.4.11.2       Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.5        Fungal and Other Pathogens

9.5.1        Overview

9.5.2        Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.       PCR for Respiratory Infection Diagnostics Market– By End User

10.1      Overview

10.2      PCR for Respiratory Infection Diagnostics Market Revenue Share, by End User (2020 and 2028)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.4      Physician Clinics

10.4.1     Overview

10.4.2     Physician Clinics: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.5      Clinical Laboratories

10.5.1     Overview

10.5.2     Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.6      Academic and Research Institutions

10.6.1     Overview

10.6.2     Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.7      Biotech and Pharma Companies

10.7.1     Overview

10.7.2     Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.8      Others

10.8.1     Overview

10.8.2     Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

11.       PCR for Respiratory Infection Diagnostics Market – Regional Analysis

11.1      Europe: PCR for Respiratory Infection Diagnostics Market

11.1.1     Overview

11.1.2     Europe: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.3     Europe: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.1.4     Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.5     Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

11.1.5.1       Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

11.1.5.2       Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

11.1.6     Europe: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7     Europe: PCR for Respiratory Infection Diagnostics Market, by Country, 2020 & 2028 (%)

11.1.8     Germany: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.1       Germany: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.2       Germany: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.1.8.3       Germany: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.8.4       Germany: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

11.1.8.4.1       Germany: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections– Revenue and Forecast to 2028 (USD Million)

11.1.8.4.2       Germany: PCR for Respiratory Infection Diagnostics Market, by Viral Infections– Revenue and Forecast to 2028 (USD Million)

11.1.8.5       Germany: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.9     UK: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.1       UK: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.2       UK: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.1.9.3       UK: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.9.4       UK: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

11.1.9.4.1       UK: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections– Revenue and Forecast to 2028 (USD Million)

11.1.9.4.2       UK: PCR for Respiratory Infection Diagnostics Market, by Viral Infections– Revenue and Forecast to 2028 (USD Million)

11.1.9.5       UK: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.10   Norway: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.10.1    Norway: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.10.2    Norway: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.1.10.3    Norway: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.10.4    Norway: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

11.1.10.4.1    Norway: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections– Revenue and Forecast to 2028 (USD Million)

11.1.10.4.2    Norway: PCR for Respiratory Infection Diagnostics Market, by Viral Infections– Revenue and Forecast to 2028 (USD Million)

11.1.10.5    Norway: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.11   Netherlands: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.11.1    Netherlands: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.11.2    Netherlands: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.1.11.3    Netherlands: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.11.4    Netherlands: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

11.1.11.4.1    Netherlands: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections– Revenue and Forecast to 2028 (USD Million)

11.1.11.4.2    Netherlands: PCR for Respiratory Infection Diagnostics Market, by Viral Infections– Revenue and Forecast to 2028 (USD Million)

11.1.11.5    Netherlands: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.12   Rest of Europe: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.12.1    Rest of Europe: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.12.2    Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.1.12.3    Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.12.4    Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

11.1.12.4.1    Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections– Revenue and Forecast to 2028 (USD Million)

11.1.12.4.2    Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections– Revenue and Forecast to 2028 (USD Million)

11.1.12.5    Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

12.       Impact Of COVID-19 Pandemic on PCR for Respiratory Infection Diagnostics Market

12.1      Europe: Impact Assessment of COVID-19 Pandemic

13.       PCR For Respiratory Infection Diagnostics Market–Industry Landscape

13.1      Overview

13.2      Growth Strategies in the PCR For Respiratory Infection Diagnostics Market, 2020-2021

13.3      Inorganic Growth Strategies

13.3.1     Overview

13.4      Organic Growth Strategies

13.4.1     Overview

14.       Company Profiles

14.1      Abbott

14.1.1     ey Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      F. HOFFMANN-LA ROCHE LTD.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Hologic, Inc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      BD

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      BIO-RAD LABORATORIES INC.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      bioMerieux SA

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      QIAGEN

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      THERMO FISHER SCIENTIFIC INC.

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Seegene Inc

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   AusDiagnostics

14.10.1   Key Facts

14.10.2   Business Description

14.10.3   Products and Services

14.10.4   Financial Overview

14.10.5   SWOT Analysis

14.10.6   Key Developments

15.       Appendix

15.1      Glossary of Terms

 

LIST OF TABLES

Table 1.            Europe: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 2.            Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3.            Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 4.            Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 5.            Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 6.            Europe: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7.            Germany: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 8.            Germany: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 9.            Germany: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 10.          Germany: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 11.          Germany: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 12.          Germany: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          UK: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 14.          UK: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          UK: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 16.          UK: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 17.          UK: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 18.          UK: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 19.          Norway: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 20.          Norway: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 21.          Norway: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 22.          Norway: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 23.          Norway: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 24.          Norway: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 25.          Netherlands: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 26.          Netherlands: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 27.          Netherlands: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 28.          Netherlands: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 29.            Netherlands: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 30.          Netherlands: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 31.          Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 32.          Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 33.          Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 34.          Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 35.          Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 36.          Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 37.          Recent Inorganic Growth Strategies in the PCR For Respiratory Infection Diagnostics Market

Table 38.          Recent Organic Growth Strategies in the PCR For Respiratory Infection Diagnostics Market

Table 39.          Glossary of Terms, PCR for Respiratory Infection Diagnostics Market

 

LIST OF FIGURES

Figure 1.           PCR for Respiratory Infection Diagnostics Market Segmentation

Figure 2.           PCR for Respiratory Infection Diagnostics Market, By Region

Figure 3.           Europe PCR for Respiratory Infection Diagnostics Market Overview

Figure 4.           Real-Time PCR (qPCR) Segment Held Largest Share of Type Segment In PCR for Respiratory Infection Diagnostics Market

Figure 5.           The UK Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Europe PCR for Respiratory Infection Diagnostics Market, Industry Landscape

Figure 7.           Europe PEST Analysis

Figure 8.           Expert Opinion

Figure 9.           PCR for Respiratory Infection Diagnostics Market Impact Analysis of Drivers and Restraint

Figure 10.        Europe PCR for Respiratory Infection Diagnostics Market – Revenue Forecast And Analysis – 2021- 2028

Figure 11.        Europe PCR for Respiratory Infection Diagnostics Market – 2021- 2028

Figure 12.        PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2020 and 2028)

Figure 13.        Real Time PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Multiplex PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Traditional PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Digital PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Others: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        PCR for Respiratory Infection Diagnostics Market Revenue Share, by Product Type (2020 and 2028)

Figure 20.        Reagents and kits: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Instruments: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Others: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        PCR for Respiratory Infection Diagnostics Market Share, by Infection Type, 2020 and 2028 (%)

Figure 24.        Bacterial Infection: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 25.        Bordetella: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 26.        Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 27.        Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 28.        Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 29.        Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 30.        Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 31.        Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 32.        Legionella: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 33.        Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 34.        Viral Infection: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 35.        Rhinoviruses: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 36.        Influenza Virus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 37.        Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 38.        Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 39.        Adenovirus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 40.        Enterovirus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 41.        Parainfluenza: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 42.        Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 43.        Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 44.        Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 45.        PCR for Respiratory Infection Diagnostics Market Share, by End User, 2020 and 2028 (%)

Figure 46.        Hospitals: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 47.        Physician Clinics: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 48.        Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 49.        Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 50.        Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 51.        Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 52.        Europe: PCR for Respiratory Infection Diagnostics Market, by Key Country – Revenue (2020) (USD Million)

Figure 53.        Europe: PCR for Respiratory Infection Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 54.        Europe: PCR for Respiratory Infection Diagnostics Market, by Country, 2020 & 2028 (%)

Figure 55.        Germany: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 56.        UK: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 57.        Norway: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 58.        Netherlands: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 59.        Rest of Europe: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 60.        Impact of COVID-19 Pandemic in European Country Markets

Figure 61.          Growth Strategies in the PCR For Respiratory Infection Diagnostics Market, 2020-2021 

The List of Companies - Europe PCR for Respiratory Infection Diagnostics Market

  1. Abbott
  2. F. Hoffmann-LA Roche Ltd.
  3. Hologic, Inc.
  4. BD
  5. Bio-Rad Laboratories Inc.
  6. bioMerieux SA
  7. Qiagen
  8. Thermo Fisher Scientific Inc
  9. Seegene Inc
  10. AusDiagnostics
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe PCR for respiratory infection diagnostics market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the Europe PCR for respiratory infection diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00023049
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing